La Trobe Institute for Molecular Science Research Fellowships 2011
UK snubs Herceptin, Tykerb use with hormone drugs (Reuters, 15 December 2010)

Slim spoils for obesity drugs (Nature News, 14 December 2010)

14 Dec 2010

Contrave is the first drug for more than 10 years to be approved by the US Food and Drug Administration as a weight-loss treatment for obesity. The role of the pharmaceutical industry in this field is discussed in an article in Nature.

Full article

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read